BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38128121)

  • 1. Spleen function is reduced in individuals with NR5A1 variants with or without a difference of sex development: a cross-sectional study.
    Cools M; Grijp C; Neirinck J; Tavernier SJ; Schelstraete P; Van De Velde J; Morbée L; De Baere E; Bonroy C; van Bever Y; Bruggenwirth H; Vermont C; Hannema SE; De Rijke Y; Abdulhadi-Atwan M; Zangen D; Verdin H; Haerynck F
    Eur J Endocrinol; 2024 Jan; 190(1):34-43. PubMed ID: 38128121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants of
    Martínez de LaPiscina I; Mahmoud RA; Sauter KS; Esteva I; Alonso M; Costa I; Rial-Rodriguez JM; Rodríguez-Estévez A; Vela A; Castano L; Flück CE
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad phenotypes in heterozygous NR5A1 46,XY patients with a disorder of sex development: an oligogenic origin?
    Camats N; Fernández-Cancio M; Audí L; Schaller A; Flück CE
    Eur J Hum Genet; 2018 Sep; 26(9):1329-1338. PubMed ID: 29891883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic reanalysis of patients with a difference of sex development carrying the NR5A1/SF-1 variant p.Gly146Ala has discovered other likely disease-causing variations.
    Martinez de Lapiscina I; Kouri C; Aurrekoetxea J; Sanchez M; Naamneh Elzenaty R; Sauter KS; Camats N; Grau G; Rica I; Rodriguez A; Vela A; Cortazar A; Alonso-Cerezo MC; Bahillo P; Bertholt L; Esteva I; Castaño L; Flück CE
    PLoS One; 2023; 18(7):e0287515. PubMed ID: 37432935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SF1 and spleen development: new heterozygous mutation, literature review and consequences for NR5A1-mutated patient's management.
    Colson C; Aubry E; Cartigny M; Rémy AA; Franquet H; Leroy X; Kéchid G; Lefèvre C; Besson R; Cools M; Spinoit AF; Sultan C; Manouvrier S; Philibert P; Ghoumid J
    Clin Genet; 2017 Jul; 92(1):99-103. PubMed ID: 28032338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and genetic characteristics of a large international cohort of individuals with rare NR5A1/SF-1 variants of sex development.
    Kouri C; Sommer G; Martinez de Lapiscina I; Elzenaty RN; Tack LJW; Cools M; Ahmed SF; Flück CE;
    EBioMedicine; 2024 Jan; 99():104941. PubMed ID: 38168586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and functional analysis of fourteen NR5A1 variants in patients with the 46 XY disorders of sex development.
    Na X; Mao Y; Tang Y; Jiang W; Yu J; Cao L; Yang J
    Gene; 2020 Nov; 760():145004. PubMed ID: 32738419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update--steroidogenic factor 1 (SF-1, NR5A1).
    Köhler B; Achermann JC
    Minerva Endocrinol; 2010 Jun; 35(2):73-86. PubMed ID: 20595937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel p.Cys65Tyr mutation in NR5A1 gene in three 46,XY siblings with normal testosterone levels and their mother with primary ovarian insufficiency.
    Fabbri HC; de Andrade JG; Soardi FC; de Calais FL; Petroli RJ; Maciel-Guerra AT; Guerra-Júnior G; de Mello MP
    BMC Med Genet; 2014 Jan; 15():7. PubMed ID: 24405868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wide spectrum of NR5A1-related phenotypes in 46,XY and 46,XX individuals.
    Domenice S; Machado AZ; Ferreira FM; Ferraz-de-Souza B; Lerario AM; Lin L; Nishi MY; Gomes NL; da Silva TE; Silva RB; Correa RV; Montenegro LR; Narciso A; Costa EM; Achermann JC; Mendonca BB
    Birth Defects Res C Embryo Today; 2016 Dec; 108(4):309-320. PubMed ID: 28033660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Heterozygous Mutations of NR5A1 and Their Functional Characteristics in Patients with 46,XY Disorders of Sex Development without Adrenal Insufficiency.
    Woo KH; Cheon B; Kim JH; Cho J; Kim GH; Yoo HW; Choi JH
    Horm Res Paediatr; 2015; 84(2):116-23. PubMed ID: 26139438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the gene coding for steroidogenic factor 1 (SF1, NR5A1) in a cohort of 50 Egyptian patients with 46,XY disorders of sex development.
    Tantawy S; Mazen I; Soliman H; Anwar G; Atef A; El-Gammal M; El-Kotoury A; Mekkawy M; Torky A; Rudolf A; Schrumpf P; Grüters A; Krude H; Dumargne MC; Astudillo R; Bashamboo A; Biebermann H; Köhler B
    Eur J Endocrinol; 2014 May; 170(5):759-67. PubMed ID: 24591553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A report of two novel NR5A1 mutation families: possible clinical phenotype of psychiatric symptoms of anxiety and/or depression.
    Suwanai AS; Ishii T; Haruna H; Yamataka A; Narumi S; Fukuzawa R; Ogata T; Hasegawa T
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):957-65. PubMed ID: 23095176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel homozygous
    Kırkgöz T; Gürsoy S; Acar S; Köprülü Ö; Özkaya B; Arslan G; Nalbantoğlu Ö; Hazan F; Özkan B
    J Pediatr Endocrinol Metab; 2024 Jun; 37(6):575-579. PubMed ID: 38650427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 46,XX Ovotesticular Disorder of Sex Development Likely Caused by a Steroidogenic Factor-1 (NR5A1) Variant.
    Swartz JM; Ciarlo R; Guo MH; Abrha A; Weaver B; Diamond DA; Chan YM; Hirschhorn JN
    Horm Res Paediatr; 2017; 87(3):191-195. PubMed ID: 27855412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and molecular characteristics of patients with 46,XY DSD due to NR5A1 gene mutations].
    Kalinchenko NY; Kolodkina AA; Raygorodskaya NY; Tiulpakov AN
    Probl Endokrinol (Mosk); 2020 Sep; 66(3):62-69. PubMed ID: 33351340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of five NR5A1 gene mutations found in patients with 46,XY disorders of sex development.
    Fabbri-Scallet H; de Mello MP; Guerra-Júnior G; Maciel-Guerra AT; de Andrade JGR; de Queiroz CMC; Monlleó IL; Struve D; Hiort O; Werner R
    Hum Mutat; 2018 Jan; 39(1):114-123. PubMed ID: 29027717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten novel mutations in the NR5A1 gene cause disordered sex development in 46,XY and ovarian insufficiency in 46,XX individuals.
    Camats N; Pandey AV; Fernández-Cancio M; Andaluz P; Janner M; Torán N; Moreno F; Bereket A; Akcay T; García-García E; Muñoz MT; Gracia R; Nistal M; Castaño L; Mullis PE; Carrascosa A; Audí L; Flück CE
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1294-306. PubMed ID: 22549935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of the multiplex ligation-dependent probe amplification in the identification of a novel two-exon deletion of the NR5A1 gene in a patient with 46,XY differences of sex development.
    Nagy O; Kárteszi J; Hartwig M; Bertalan R; Jávorszky E; Erhardt É; Patócs A; Tornóczky T; Balogh I; Ujfalusi A
    Mol Biol Rep; 2019 Oct; 46(5):5595-5601. PubMed ID: 31338750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of novel NR5A1 variants reveals multiple complex roles in disorders of sex development.
    Robevska G; van den Bergen JA; Ohnesorg T; Eggers S; Hanna C; Hersmus R; Thompson EM; Baxendale A; Verge CF; Lafferty AR; Marzuki NS; Santosa A; Listyasari NA; Riedl S; Warne G; Looijenga L; Faradz S; Ayers KL; Sinclair AH
    Hum Mutat; 2018 Jan; 39(1):124-139. PubMed ID: 29027299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.